HeartSciences Research and Development Expenses 2022-2024 | HSCS
HeartSciences research and development expenses from 2022 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
| HeartSciences Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023 | $2 |
| 2022 | $3 |
| 2021 | $2 |
| HeartSciences Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024-01-31 | $1 |
| 2023-10-31 | $1 |
| 2023-07-31 | $1 |
| 2023-04-30 | $1 |
| 2023-01-31 | $1 |
| 2022-10-31 | $1 |
| 2022-07-31 | $0 |
| 2022-04-30 | $1 |
| 2022-01-31 | $1 |
| 2021-10-31 | $1 |
| 2021-07-31 | $0 |
| 2021-04-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.004B | $0.000B |
| HeartSciences is an artificial intelligence powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. The company's product candidate includes the MyoVista(R) wavECG(TM) or the MyoVista(R). HeartSciences , formerly known as Heart Test Laboratories Inc., is based in Southlake, TX. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $35.810B | 19.66 |
| Inspire Medical Systems (INSP) | United States | $4.766B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $4.206B | 0.00 |
| Axonics (AXNX) | United States | $3.419B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.988B | 0.00 |
| Azenta (AZTA) | United States | $2.744B | 154.24 |
| Enovis (ENOV) | United States | $2.713B | 20.11 |
| IRhythm Technologies (IRTC) | United States | $2.698B | 0.00 |
| 10x Genomics (TXG) | United States | $2.635B | 0.00 |
| Privia Health (PRVA) | United States | $1.957B | 109.33 |
| Schrodinger (SDGR) | United States | $1.556B | 0.00 |
| Omnicell (OMCL) | United States | $1.461B | 50.49 |
| Phreesia (PHR) | United States | $1.251B | 0.00 |
| Standard BioTools (LAB) | United States | $0.965B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.625B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.624B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.511B | 0.00 |
| Talkspace (TALK) | United States | $0.453B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.386B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.336B | 0.00 |
| Pulmonx (LUNG) | United States | $0.292B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.211B | 0.00 |
| Outset Medical (OM) | United States | $0.197B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.172B | 0.00 |
| TruBridge (TBRG) | United States | $0.139B | 7.46 |
| American Well (AMWL) | United States | $0.123B | 0.00 |
| 111 (YI) | China | $0.105B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.100B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.080B | 0.00 |
| HeartBeam (BEAT) | United States | $0.077B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.065B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| Augmedix (AUGX) | United States | $0.056B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.054B | 0.00 |
| CareCloud (CCLD) | United States | $0.046B | 0.00 |
| Zepp Health (ZEPP) | China | $0.045B | 0.00 |
| Movano (MOVE) | United States | $0.037B | 0.00 |
| Akili (AKLI) | United States | $0.033B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.029B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.026B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.021B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Biotricity (BTCY) | United States | $0.011B | 0.00 |
| Syra Health (SYRA) | United States | $0.009B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| Cue Health (HLTH) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |